Lipocine Inc. (LPCN) Financials

LPCN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 23.0 million 2.6 million
2023-09-30 24.8 million 2.3 million
2023-06-30 30.5 million 1.9 million
2023-03-31 34.0 million 2.1 million

LPCN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -2.0 million 153711
2023-09-30 -2.6 million 158090
2023-06-30 -3.3 million 164865
2023-03-31 -3.9 million 177772

LPCN Net Income

No data available :(

LPCN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 22.0 million - -
2023-09-30 23.8 million - -
2023-06-30 25.8 million - -
2023-03-31 28.9 million - -

LPCN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 5.3 million
2023-09-30 5.3 million
2023-06-30 5.2 million
2023-03-31 5.2 million

LPCN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 9167 1.7 million 1.1 million -
2023-09-30 - 2.9 million 1.0 million -
2023-06-30 - 2.5 million 1.4 million -
2023-03-31 4000 3.1 million 1.3 million -

LPCN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 54997 8003
2023-09-30 -3.1 million 6.0 million
2023-06-30 - 2.5 million
2023-03-31 54990 4819

LPCN

Price: $4.92

52 week price:
2.31
6.51

Earnings Per Share: -3.14 USD

P/E Ratio: -1.25

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 27881

Ebitda: -4.8 million

Market Capitalization: 30.7 million

Links: